Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “or Severe Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07793929
What this trial is testing

Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

Who this might be right for
End Stage Renal DiseaseRenal ImpairmentObesity+1 more
Kailera 32
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Large-scale testing (Phase 3)Ended earlyNCT02647255
What this trial is testing

Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAKidney DiseasesAcute Renal Insufficiency+1 more
Peking University First Hospital 10
Early research (Phase 1)Study completedNCT06723535
What this trial is testing

Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Who this might be right for
Kidney Failure, ChronicHealthy VolunteersRenal Impairment
Bristol-Myers Squibb 27
Large-scale testing (Phase 3)Study completedNCT00646542
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 525
Not applicableLooking for participantsNCT06243731
What this trial is testing

Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Who this might be right for
Cytomegalovirus (CMV)Kidney DiseaseKidney Failure
Takeda 10
Early research (Phase 1)Study completedNCT00791401
What this trial is testing

The Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

Who this might be right for
SchizophreniaRenal Impairment
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Early research (Phase 1)Study completedNCT06911320
What this trial is testing

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

Who this might be right for
Healthy Volunteer StudyHepatic ImpairmentRenal Impairment
Atea Pharmaceuticals, Inc. 28
Post-approval studies (Phase 4)Study completedNCT02864199
What this trial is testing

Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 63
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Post-approval studies (Phase 4)Study completedNCT01336140
What this trial is testing

Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging

Who this might be right for
Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson
Rush University Medical Center 300
Large-scale testing (Phase 3)Study completedNCT01087502
What this trial is testing

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT03011450
What this trial is testing

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Who this might be right for
Severe Hypertriglyceridemia
Kowa Research Institute, Inc. 471
Post-approval studies (Phase 4)UnknownNCT02459288
What this trial is testing

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients

Who this might be right for
Acute Coronary SyndromeChronic Kidney DiseaseEnd-Stage Renal Disease
Ping-Yen Liu 80
Early research (Phase 1)Study completedNCT01504165
What this trial is testing

Pharmacokinetics in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Merck KGaA, Darmstadt, Germany 32
Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Early research (Phase 1)Looking for participantsNCT07559396
What this trial is testing

Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease

Who this might be right for
Renal Impairment
Incyte Corporation 16
Testing effectiveness (Phase 2)Study completedNCT02977494
What this trial is testing

Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 22
Testing effectiveness (Phase 2)Study completedNCT01447914
What this trial is testing

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
National Cancer Institute (NCI) 16
Next Page